Production (Stage)
Intellia Therapeutics, Inc.
NTLA
$8.29
$0.202.47%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 503.75M | 601.52M | 658.11M | 691.07M | 791.29M |
| Total Receivables | 10.50M | 8.52M | 8.85M | 12.33M | 36.43M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 37.14M | 29.83M | 43.93M | 53.81M | 56.32M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 551.39M | 639.86M | 710.90M | 757.21M | 884.04M |
|
|
|||||
| Total Current Assets | 551.39M | 639.86M | 710.90M | 757.21M | 884.04M |
| Net Property, Plant & Equipment | 163.10M | 246.67M | 129.09M | 135.69M | 142.50M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 43.57M | 17.39M | 16.84M | 16.82M | 17.59M |
| Total Assets | 986.16M | 1.19B | 1.17B | 1.19B | 1.26B |
|
|
|||||
| Total Accounts Payable | 12.36M | 14.59M | 13.15M | 18.82M | 13.69M |
| Total Accrued Expenses | 40.81M | 55.36M | 49.86M | 42.80M | 39.28M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 38.76M | 20.25M | 19.18M | 18.96M | 18.76M |
| Total Finance Division Other Current Liabilities | 20.66M | 20.66M | 23.50M | 24.51M | 26.18M |
| Total Other Current Liabilities | 20.66M | 20.66M | 23.50M | 24.51M | 26.18M |
| Total Current Liabilities | 112.59M | 110.85M | 105.68M | 105.09M | 97.91M |
|
|
|||||
| Total Current Liabilities | 112.59M | 110.85M | 105.68M | 105.09M | 97.91M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 80.49M | 189.95M | 82.45M | 87.33M | 92.10M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.16M | 18.26M | 22.61M | 28.05M | 33.44M |
| Total Liabilities | 206.24M | 319.06M | 210.74M | 220.47M | 223.45M |
|
|
|||||
| Common Stock & APIC | 3.07B | 3.05B | 3.01B | 2.89B | 2.80B |
| Retained Earnings | -2.29B | -2.18B | -2.05B | -1.91B | -1.77B |
| Treasury Stock & Other | 1.06M | 605.00K | 3.30M | -1.16M | -947.00K |
| Total Common Equity | 779.92M | 871.96M | 962.62M | 971.06M | 1.04B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 779.92M | 871.96M | 962.62M | 971.06M | 1.04B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 779.92M | 871.96M | 962.62M | 971.06M | 1.04B |
|
|
|||||